Cytheris is interested in discussing partnering opportunities to develop and commercially support products that address unmet medical needs by reconstituting and enhancing the immune system.

At present, the company is focused on building its IL-7 therapeutic franchise to treat patients suffering from infectious disease, cancer, lympho-depleting treatments and related diseases and conditions through partnerships and alliances.

For more information about business and corporate development opportunities, please direct inquiries to:

Richard W. Keatinge
Chief Business Officer
Tel: +33 (0) 1 58 88 35 81 (direct)
E-mail: rkeatinge@cytheris.com
Download vCard